The USFDA has approved Teva Pharmaceutical Industries' abbreviated new drug application (ANDA) for generic Adderall XR capsules to treat attention deficit hyperactivity disorder. The ANDA is concerned with generic version of Shire's ...
Tags: FDA, Teva Pharmaceutical Industries, ANDA, Adderall XR capsules